| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |